Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.64 |
| ▸ | ITGAV | P06756 | 20/20 | 0.64 |
| ▸ | ITGB5 | P18084 | 12/20 | 0.64 |
| ▸ | ITGB6 | P18564 | 11/20 | 0.64 |
| ▸ | ITGB8 | P26012 | 11/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24521881 | 0.86 | ITGB3 (0.56) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL24521902 | 0.85 | ITGB3 (0.61) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL24521899 | 0.85 | ITGB3 (0.67) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL20153338 | 0.85 | ITGB3 (0.59) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL20153397 | 0.83 | ITGB3 (0.56) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL7447166 | 0.80 | ITGAV (0.63) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL7434301 | 0.80 | ITGAV (0.63) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL7434288 | 0.80 | ITGAV (0.63) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL24521897 | 0.79 | ITGAV (0.51) | ITGB3ITGAVITGB5ITGB6ITGB8 | |
| SCHEMBL20139872 | 0.78 | ITGB3 (0.67) | ITGB3ITGAVITGB5ITGB6ITGB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538525-B1 | 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2022-06-22 | — | — | EP | disclosed |
| WO-2018089353-A1 | 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-17 | — | — | WO | disclosed |